These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1053468)

  • 1. Furosemide and plasma renin activity in essential hypertension.
    Hutcheon DE; Sandhu R
    Angiology; 1976 Oct; 27(10):579-86. PubMed ID: 1053468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of salt restriction and furosemide in patients investigated for renovascular hypertension.
    Mörlin C; Aberg H
    Acta Chir Scand; 1981; 147(3):169-72. PubMed ID: 7036614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes in plasma renin activity and plasma catecholamines in mildly hypertensive patients during acute, furosemide-induced body-fluid loss.
    Cannella G; Galva MD; Campanini M; Cesura AM; De Marinis S; Picotti GB
    Eur J Clin Pharmacol; 1983; 25(3):299-302. PubMed ID: 6354727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants.
    Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E
    Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced renin levels after discontinuation of furosemide: additional effects of loop diuretics on renin release.
    Tuck ML; Sambhi MP; Kramer SB; Eggena P; Barrett J
    Clin Exp Hypertens A; 1982; 4(8):1359-75. PubMed ID: 6749346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension.
    Laffer CL; Laniado-Schwartzman M; Wang MH; Nasjletti A; Elijovich F
    Hypertension; 2003 Mar; 41(3 Pt 2):703-8. PubMed ID: 12623983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
    Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
    Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atenolol and enalapril on blood pressure, plasma renin activity and urinary prostanoids.
    Wilson TW
    Clin Invest Med; 1988 Jun; 11(3):203-8. PubMed ID: 2841053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].
    Kolloch R; Stumpe KO; Higuchi M; Vetter H; Krück F
    Klin Wochenschr; 1977 Oct; 55(20):1013-8. PubMed ID: 926711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man.
    Patak RV; Mookerjee BK; Bentzel CJ; Hysert PE; Babej M; Lee JB
    Prostaglandins; 1975 Oct; 10(4):649-59. PubMed ID: 1105697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between renin responsiveness to furosemide and antihypertensive effect of captopril in patients with normal-renin essential hypertension.
    Fang CC; Chen YM; Chu TS; Hsieh BS
    J Formos Med Assoc; 1993 Nov; 92(11):937-41. PubMed ID: 7910062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
    Tanaka K; Fukiyama K; Kumamoto K; Yamamoto Y; Oniki H; Omae T
    Jpn Circ J; 1975 Jul; 39(7):805-10. PubMed ID: 1159940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.